The LBI-RUD has been founded to implement a coordinated research program on the genetic and functional basis of rare diseases. Rare diseases are paradigmatic for the upcoming era of personalized and participatory medicine, and LBI-RUD broadly embraces its pioneering role for the future of medicine with the vision to provide an internationally visible contribution to its realization. The LBI-RUD partners Medical University of Vienna (MedUni Vienna), with the largest university hospital in Europe, the St. Anna Children’s Cancer Research Institute (CCRI), and the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, provide an ideal interface to bridge state-of-the-art research and clinical practice. With their support, LBI-RUD has been deeply integrated into the national network to diagnose, characterize, and treat rare genetic defects as an active part within the Vienna Center for Rare and Undiagnosed Diseases (CeRUD).
The Stary group at LBI-RUD focuses on the characterization of host-pathogen interactions in the skin and on mucosal membranes. The combination of high-level clinical research with human tissue as well as mouse models are ideally suited to successfully translate research results to clinics.
More information can be found on the website of the LBI-RUD.